Watertown, Massachusetts — According to state and local development sources, LifeMine Therapeutics plans to build out 117,645 square feet of new space in Watertown. The company plans to occupy the new space at 66 Galen…
According to filings with the U.S. Securities and Exchange Commission, Treeline Biosciences is raising up to $421,779,808.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joshua Bilenker played a…
According to filings with the U.S. Securities and Exchange Commission, Affini-T Therapeutics is raising up to $17,617,952.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joseph Knowles played a…
According to filings with the U.S. Securities and Exchange Commission, Ingenia Therapeutics is raising up to $25,000,000.00 in new funding. Sources indicate that as part of senior management President, Sangyeul Han played a key role…
Founded by Chief Executive Officer Chris Loose, Ph.D. and Chief Scientific Officer, Sanjay Magavi, Ph.D., Progentos to Drive Clinical Development of Novel Therapeutics for Remyelination Financing Led by Forbion with other Leading Life Science Investors…
According to filings with the U.S. Securities and Exchange Commission, Multitude Insights is raising up to $5,415,000.00 in new funding. Sources indicate that as part of senior management President, Matthew White played a key role…
March 04, 2024 08:00 AM Eastern Standard Time WATERTOWN, Mass.–(BUSINESS WIRE)–Nocion Therapeutics, a clinical-stage biopharmaceutical company, today announced that it has raised $62 million in Series B funding. Nocion is developing first and potentially best…
According to filings with the U.S. Securities and Exchange Commission, Entact Bio is raising up to $39,899,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Victoria Richon played a…
According to filings with the U.S. Securities and Exchange Commission, Alleviate is raising up to $1,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Roderick Mcmullen played a key…
According to filings with the U.S. Securities and Exchange Commission, Remix Therapeutics is raising $90,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Peter Smith played a…